Mediators of the improvement in heart failure outcomes with empagliflozin in the EMPA-REG OUTCOME trial.
Fitchett D, Inzucchi SE, Zinman B, Wanner C, Schumacher M, Schmoor C, Ohneberg K, Ofstad AP, Salsali A, George JT, Hantel S, Bluhmki E, Lachin JM, Zannad F.
Fitchett D, et al. Among authors: ohneberg k.
ESC Heart Fail. 2021 Dec;8(6):4517-4527. doi: 10.1002/ehf2.13615. Epub 2021 Oct 4.
ESC Heart Fail. 2021.
PMID: 34605192
Free PMC article.